A company once owned by ‘Pharma Bro’ Martin Shkreli will pay up to US$40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4,000 per cent after obtaining exclusive rights to the drug, the Federal Trade Commission announced Tuesday.
Source: ctv business
‘Pharma Bro’ firm reaches USM settlement in gouging case

